TMO Thermo Fisher Scientific Loading... : Bullish and Bearish Analyst Opinions
From CRL earnings callsLoading chart...
Top Calls
Feed
12:30
May 07
May 07
AI-assisted drug discovery companies typically work on many more programs simultaneously than traditional biotechs, which could increase the volume of preclinical work that gets outsourced to CRL. — As AI-native drug developers scale, they are more likely to outsource their 'wet lab' work, creating a new and potentially larger pipeline of customers for contract research organizations.
MED
About TMO Analyst Coverage
Buzzberg tracks TMO (Thermo Fisher Scientific) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Birgit Flaten.